Disulfiram targets cancer stem-like cells and reverses resistance and cross-resistance in acquired paclitaxel-resistant triple-negative breast cancer cells. [electronic resource]
Producer: 20131204Description: 1876-85 p. digitalISSN:- 1532-1827
- Antineoplastic Agents, Phytogenic -- pharmacology
- Breast Neoplasms -- drug therapy
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cisplatin -- pharmacology
- Disulfiram -- pharmacology
- Docetaxel
- Doxorubicin -- pharmacology
- Drug Resistance, Neoplasm -- drug effects
- Enzyme Inhibitors -- pharmacology
- ErbB Receptors -- metabolism
- Female
- Humans
- Neoplastic Stem Cells -- drug effects
- Paclitaxel -- pharmacology
- Receptors, Estrogen -- metabolism
- Receptors, Progesterone -- metabolism
- Taxoids -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.